Correlates of stocking naloxone: A cross sectional survey of community pharmacists

Author:

Laing Rose1ORCID,Xia Ting2,Grist Elizabeth2,Dostal Jana3,Nielsen Suzanne2,Picco Louisa2

Affiliation:

1. Monash University

2. : Monash University Eastern Health Clinical School

3. Monash University Eastern Health Clinical School

Abstract

Abstract

Introduction: Provision of take-home naloxone (THN) and overdose education reduces opioid-related mortality. In Australia, from July 2022, all Australian community pharmacies were eligible to supply naloxone for free through the national Take Home Naloxone Program. This study aims to identify naloxone stocking rates and correlates of stocking naloxone across Australian pharmacies. Method: Data was collected from a representative sample of Australian pharmacists in Victoria, New South Wales, Queensland and Western Australia via an online survey. Data collected included pharmacy and pharmacist characteristics and services offered within the pharmacy, including needle and syringe programs, opioid agonist treatment (OAT) and stocking naloxone. Binary probit regression analysis was used to identify correlates of stocking naloxone after controlling for key covariates. Results: Data from 530 pharmacists were analysed. In total, 321 pharmacies (60.6%) reported stocking naloxone. Chain and banner pharmacies and pharmacies that provided OAT had a greater probability of stocking naloxone (B = 0.307, 95%CI: [0.057, 0.556], and B = 0.543, 95%CI: [0.308, 0.777] respectively). Most (61.7%) pharmacists felt comfortable discussing overdose prevention with patients who use prescription opioids, and this comfort was associated with a higher probability of stocking naloxone (B = 0.392, 95%CI: 0.128, 0.655). Comfort discussing overdose prevention with people who use illicit opioids was lower (49.4%) and was not associated with stocking naloxone. Conclusion: There is scope to increase stocking of naloxone and comfort with overdose prevention, particularly through addressing comfort working with higher risk groups such as people who use illicit opioids.

Publisher

Springer Science and Business Media LLC

Reference50 articles.

1. Pharmaceutical opioid poisonings in Victoria, Australia: Rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids;Lam T;Addiction,2022

2. How to Combat the Global Opioid Crisis;Dennen AC;CPQ Neurol Psychol,2023

3. United Nations Office on Drugs and Crime. World Drug Report 2023: Special Points of Interest: UNODC Research2023.

4. Chechak D. The Opioid Crisis in Canada. Responding to the Oppression of Addiction: Canadian Social Work Perspectives. 2023:60.

5. Opioid Prescribing Patterns Before Fatal Opioid Overdose;Abbasi AB;Am J Prev Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3